Abstract
Multi-criteria decision analysis is a benefit-risk assessment tool that evaluates multiple competing benefit and risk criteria simultaneously. This has the potential to aid sponsors in making effective and informed go/no-go decisions for their clinical development program. This method involves assigning weights to various benefit and risk criteria based on their relative importance (utility weight) and summing them to compute a single utility score that represents the overall benefit-risk profile of the treatment. However, this approach is constrained to binary and continuous parameters. In this paper, we introduce a novel framework known as Bayesian Multi-Criteria Augmented Decision Analysis (MCADA), which extends existing methods to encompass time-to-event and ordinal outcomes while incorporating linear and novel non-linear functions in utility aggregation. This paper provides a comprehensive description of the statistical methodology behind the MCADA framework and demonstrates its application using IPD and aggregate data from two clinical trials. Our two case studies show that the MCADA framework can be effectively used to produce a single utility score that reflects the overall benefit-risk profile of the treatment using both IPD and aggregate data from trials. MCADA broadens the horizon of the existing MCDA framework by accommodating a wider range of data types and utility functions in the utility aggregation process.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This publication is based on research using information obtained from www.projectdatasphere.org, which is maintained by Project Data Sphere. Neither Project Data Sphere nor the owner(s) of any information from the web site have contributed to, approved or are in any way responsible for the contents of this publication. Using anonymous data from Project Data Sphere. Our institutional policy requires no ethics approval or waiver due to anonymized data.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
This publication is based on research using information obtained from www.projectdatasphere.org, which is maintained by Project Data Sphere.
